Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRES – Dexamethasone to reduce reoperation in chronic subdural hematoma
2011-003544-42Phase 3Completed
- Sponsor
- Department of Neurosurgery, Paracelsus Medical University
- Start
- Nov 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chronic subdural haematoma (CSDH) comparing Dexamethasone arm with Placebo arm (2 arms). Primary endpoint: Reoperation rate within 12 weeks. Started Nov 2011; status: completed.
02
Drugs
dexamethasone
03
Conditions
Chronic subdural haematoma (CSDH)
Beyond the preview
Go deeper on 2011-003544-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003544-42.